¿ Existe el cáncer localizado de próstata?

Descripción del Articulo

The natural history of prostate cancer is not well defined and this further complicates the therapeutic options for its treatment. Since 1980, radical prostatectomy was considered the first option in attempting to cure this type of cancer which represents a 25% of the cases of cancer in men, affecti...

Descripción completa

Detalles Bibliográficos
Autores: Lobel Mandel, Bernard, Guille Sendrales, Francois, Patard Roulier, Jean-Jacques, Zegarra Montes, Luis
Formato: artículo
Fecha de Publicación:2013
Institución:Universidad Peruana Cayetano Heredia
Repositorio:Revistas - Universidad Peruana Cayetano Heredia
Lenguaje:español
OAI Identifier:oai:revistas.upch.edu.pe:article/836
Enlace del recurso:https://revistas.upch.edu.pe/index.php/RMH/article/view/836
Nivel de acceso:acceso abierto
id REVUPCH_ebea0c5645012460e4325b871f4caaf4
oai_identifier_str oai:revistas.upch.edu.pe:article/836
network_acronym_str REVUPCH
network_name_str Revistas - Universidad Peruana Cayetano Heredia
repository_id_str
spelling ¿ Existe el cáncer localizado de próstata?Lobel Mandel, BernardGuille Sendrales, FrancoisPatard Roulier, Jean-JacquesZegarra Montes, LuisThe natural history of prostate cancer is not well defined and this further complicates the therapeutic options for its treatment. Since 1980, radical prostatectomy was considered the first option in attempting to cure this type of cancer which represents a 25% of the cases of cancer in men, affecting 1/8 of the male population before age 75 and that reveals itself as the more frequent male cancer after age 50. Due to its effectiveness, radical prostatectomy should be performed when cancer is limited to the gland, not having surpassed the prostatic gland. The acquired experience shows that 20-40% of anatomical pieces extracted presented capsular invasion or positive margins, and that approximately 30-60% of the operated patients witness the progress of their disease within 5 years, despite surgery. This thought is possible due to the acquired experience with numerous patients that have been treated with radical prostatectomy. All the recent work done confirms that only cancer localized to the prostatic gland is susceptible of being cured by surgery and that only low risk cancers have a real possibility of being limited to the gland. In this group of patients with localized cancer, many are not of clinical importance. An important number of patients that have neoplasic cells in their prostate will die from other causes, without having necessarily suffered from the prostate. This paper highlights the limits of surgery and the actual lack of criteria to define a localized lesion within the gland and its aggressiveness, as well as the lack of alternative effective treatments in the case of an extra prostatic lesion. Finally, it is very important to try to make an early diagnosis of prostatic cancer, nevertheless, from the moment in which the diagnosis of cancer is given to the patient, the single word “cancer” sounds devastating and its announcement transforms the patient’s life, with an upcoming death sensation that could pose a psychological harm to the patient. Just to mention, for the urologist not to over estimate cancer and not to over treat it with interventions that may definitely alter the quality of life of the patient: radical prostatectomy causes urinary incontinence in 5-20% of patients and erectile disfunction in 40-70% of them. ¿ Does cancer localized to the prostate gland really exist? The question arises now between the cases of cancer that are diagnosed while they are not significative and the ones that have already surpassed the capsule.Universidad Peruana Cayetano Heredia2013-01-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed articleArtículo evaluado por paresapplication/pdfhttps://revistas.upch.edu.pe/index.php/RMH/article/view/83610.20453/rmh.v16i3.836Revista Médica Herediana; Vol. 16 No. 3 (2005): July - September; 202Revista Médica Herediana; Vol. 16 Núm. 3 (2005): julio - setiembre; 202Revista Medica Herediana; v. 16 n. 3 (2005): Julho - setembro; 2021729-214X1018-130Xreponame:Revistas - Universidad Peruana Cayetano Herediainstname:Universidad Peruana Cayetano Herediainstacron:UPCHspahttps://revistas.upch.edu.pe/index.php/RMH/article/view/836/802info:eu-repo/semantics/openAccessoai:revistas.upch.edu.pe:article/8362024-01-14T17:07:14Z
dc.title.none.fl_str_mv ¿ Existe el cáncer localizado de próstata?
title ¿ Existe el cáncer localizado de próstata?
spellingShingle ¿ Existe el cáncer localizado de próstata?
Lobel Mandel, Bernard
title_short ¿ Existe el cáncer localizado de próstata?
title_full ¿ Existe el cáncer localizado de próstata?
title_fullStr ¿ Existe el cáncer localizado de próstata?
title_full_unstemmed ¿ Existe el cáncer localizado de próstata?
title_sort ¿ Existe el cáncer localizado de próstata?
dc.creator.none.fl_str_mv Lobel Mandel, Bernard
Guille Sendrales, Francois
Patard Roulier, Jean-Jacques
Zegarra Montes, Luis
author Lobel Mandel, Bernard
author_facet Lobel Mandel, Bernard
Guille Sendrales, Francois
Patard Roulier, Jean-Jacques
Zegarra Montes, Luis
author_role author
author2 Guille Sendrales, Francois
Patard Roulier, Jean-Jacques
Zegarra Montes, Luis
author2_role author
author
author
description The natural history of prostate cancer is not well defined and this further complicates the therapeutic options for its treatment. Since 1980, radical prostatectomy was considered the first option in attempting to cure this type of cancer which represents a 25% of the cases of cancer in men, affecting 1/8 of the male population before age 75 and that reveals itself as the more frequent male cancer after age 50. Due to its effectiveness, radical prostatectomy should be performed when cancer is limited to the gland, not having surpassed the prostatic gland. The acquired experience shows that 20-40% of anatomical pieces extracted presented capsular invasion or positive margins, and that approximately 30-60% of the operated patients witness the progress of their disease within 5 years, despite surgery. This thought is possible due to the acquired experience with numerous patients that have been treated with radical prostatectomy. All the recent work done confirms that only cancer localized to the prostatic gland is susceptible of being cured by surgery and that only low risk cancers have a real possibility of being limited to the gland. In this group of patients with localized cancer, many are not of clinical importance. An important number of patients that have neoplasic cells in their prostate will die from other causes, without having necessarily suffered from the prostate. This paper highlights the limits of surgery and the actual lack of criteria to define a localized lesion within the gland and its aggressiveness, as well as the lack of alternative effective treatments in the case of an extra prostatic lesion. Finally, it is very important to try to make an early diagnosis of prostatic cancer, nevertheless, from the moment in which the diagnosis of cancer is given to the patient, the single word “cancer” sounds devastating and its announcement transforms the patient’s life, with an upcoming death sensation that could pose a psychological harm to the patient. Just to mention, for the urologist not to over estimate cancer and not to over treat it with interventions that may definitely alter the quality of life of the patient: radical prostatectomy causes urinary incontinence in 5-20% of patients and erectile disfunction in 40-70% of them. ¿ Does cancer localized to the prostate gland really exist? The question arises now between the cases of cancer that are diagnosed while they are not significative and the ones that have already surpassed the capsule.
publishDate 2013
dc.date.none.fl_str_mv 2013-01-02
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed article
Artículo evaluado por pares
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistas.upch.edu.pe/index.php/RMH/article/view/836
10.20453/rmh.v16i3.836
url https://revistas.upch.edu.pe/index.php/RMH/article/view/836
identifier_str_mv 10.20453/rmh.v16i3.836
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistas.upch.edu.pe/index.php/RMH/article/view/836/802
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Peruana Cayetano Heredia
publisher.none.fl_str_mv Universidad Peruana Cayetano Heredia
dc.source.none.fl_str_mv Revista Médica Herediana; Vol. 16 No. 3 (2005): July - September; 202
Revista Médica Herediana; Vol. 16 Núm. 3 (2005): julio - setiembre; 202
Revista Medica Herediana; v. 16 n. 3 (2005): Julho - setembro; 202
1729-214X
1018-130X
reponame:Revistas - Universidad Peruana Cayetano Heredia
instname:Universidad Peruana Cayetano Heredia
instacron:UPCH
instname_str Universidad Peruana Cayetano Heredia
instacron_str UPCH
institution UPCH
reponame_str Revistas - Universidad Peruana Cayetano Heredia
collection Revistas - Universidad Peruana Cayetano Heredia
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1844884498606456832
score 12.828746
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).